PD1 and PD-L1 inhibitors for the treatment of kidney cancer: The role of PD-L1 assay

ANTONIO LOPEZ BELTRAN2026-01-292026-01-29202010.2174/13894501216662003241510562-s2.0-85094981821https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/32514Clinical BiochemistryDrug DiscoveryMolecular MedicinePharmacologyPD1 and PD-L1 inhibitors for the treatment of kidney cancer: The role of PD-L1 assayother